Chi-Med Highlights HMPL-689 Clinical Data to Be Presented at the 62nd ASH Annual Meeting

Posted on the 05 November 2020 by Juan Sanchez @times_european

… analysis of the first in human HMPL-689 Phase I dose … Europe, with patient enrollment underway. Chi-Med currently retain all rights to …  7340 (Mobile)
bmiles@troutgroup.com
Europe – Ben Atwell / Alex Shaw …

The post Chi-Med Highlights HMPL-689 Clinical Data to be Presented at the 62nd ASH Annual Meeting first appeared on TheEuropeanTimes.INFO.